Real World Outcomes With Chemotherapy and Immunotherapy in Metastatic Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas

ABSTRACT Background Gastroenteropancreatic poorly differentiated neuroendocrine carcinomas (GEP‐NECs) are aggressive cancers where cytotoxic chemotherapy is the backbone of treatment. While the addition of immunotherapy with immune checkpoint inhibitors (IOs) to chemotherapy is recommended for lung...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Rushabh Gujarathi, Samantha Kwock, Faith Abodunrin, Namrata Setia, Xavier M. Keutgen, Chih‐Yi Liao
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2026-04-01
Edice:	Cancer Medicine
Témata:	chemotherapy immunotherapy ncdb neuroendocrine carcinomas neuroendocrine tumors
On-line přístup:	https://doi.org/10.1002/cam4.71809
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!